COVID-19 Impact on Global CD163(Antibody) Market Size, Status and Forecast 2020-2026

September 2020 | 127 pages | ID: CDD7DBD69B11EN
QYResearch

Abstracts

This report focuses on the global CD163(Antibody) status, future forecast, growth opportunity, key market and key players. The study objectives are to present the CD163(Antibody) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
The key players covered in this study

• Abbexa Ltd(UK)
• Atlas Antibodies(Sweden)
• Boster Biological Technology(USA)
• Biobyt(UK)
• Bio-Rad(US)
• Bioss Antibodies(US)
• BioLegend(US)
• Lifespan Biosciences(US)
• MBL(US)
• Novus Biologicals(US)
• ProSci(US)
• Proteintech(US)
• R&D Systems(US)
• Thermo Fisher Scientific(US)
• USBiological(US)
• Aviva Systems Biology Corporation(USA)
• Epigentek(US)

Market segment by Type, the product can be split into

• Above 90%
• Above 95%
• Above 99%
• Others

Market segment by Application, split into

• Biopharmaceutical Companies
• Hospitals
• Bioscience Research Institutions
• Others

Market segment by Regions/Countries, this report covers

• North America
• Europe
• China
• Japan
• Southeast Asia
• India
• Central & South America

The study objectives of this report are:

• To analyze global CD163(Antibody) status, future forecast, growth opportunity, key market and key players.
• To present the CD163(Antibody) development in North America, Europe, China, Japan, Southeast Asia, India and Central & South America.
• To strategically profile the key players and comprehensively analyze their development plan and strategies.
• To define, describe and forecast the market by type, market and key regions.

In this study, the years considered to estimate the market size of CD163(Antibody) are as follows:

• History Year: 2015-2019
• Base Year: 2019
• Estimated Year: 2020
• Forecast Year 2020 to 2026

For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Contents

1 REPORT OVERVIEW

1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by CD163(Antibody) Revenue
1.4 Market Analysis by Type
  1.4.1 Global CD163(Antibody) Market Size Growth Rate by Type: 2020 VS 2026
  1.4.2 Above 90%
  1.4.3 Above 95%
  1.4.4 Above 99%
  1.4.5 Others
1.5 Market by Application
  1.5.1 Global CD163(Antibody) Market Share by Application: 2020 VS 2026
  1.5.2 Biopharmaceutical Companies
  1.5.3 Hospitals
  1.5.4 Bioscience Research Institutions
  1.5.5 Others
1.6 Coronavirus Disease 2019 (Covid-19): CD163(Antibody) Industry Impact
  1.6.1 How the Covid-19 is Affecting the CD163(Antibody) Industry
    1.6.1.1 CD163(Antibody) Business Impact Assessment - Covid-19
    1.6.1.2 Supply Chain Challenges
    1.6.1.3 COVID-19’s Impact On Crude Oil and Refined Products
  1.6.2 Market Trends and CD163(Antibody) Potential Opportunities in the COVID-19 Landscape
  1.6.3 Measures / Proposal against Covid-19
    1.6.3.1 Government Measures to Combat Covid-19 Impact
    1.6.3.2 Proposal for CD163(Antibody) Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered

2 GLOBAL GROWTH TRENDS BY REGIONS

2.1 CD163(Antibody) Market Perspective (2015-2026)
2.2 CD163(Antibody) Growth Trends by Regions
  2.2.1 CD163(Antibody) Market Size by Regions: 2015 VS 2020 VS 2026
  2.2.2 CD163(Antibody) Historic Market Share by Regions (2015-2020)
  2.2.3 CD163(Antibody) Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
  2.3.1 Market Top Trends
  2.3.2 Market Drivers
  2.3.3 Market Challenges
  2.3.4 Porter’s Five Forces Analysis
  2.3.5 CD163(Antibody) Market Growth Strategy
  2.3.6 Primary Interviews with Key CD163(Antibody) Players (Opinion Leaders)

3 COMPETITION LANDSCAPE BY KEY PLAYERS

3.1 Global Top CD163(Antibody) Players by Market Size
  3.1.1 Global Top CD163(Antibody) Players by Revenue (2015-2020)
  3.1.2 Global CD163(Antibody) Revenue Market Share by Players (2015-2020)
  3.1.3 Global CD163(Antibody) Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global CD163(Antibody) Market Concentration Ratio
  3.2.1 Global CD163(Antibody) Market Concentration Ratio (CR5 and HHI)
  3.2.2 Global Top 10 and Top 5 Companies by CD163(Antibody) Revenue in 2019
3.3 CD163(Antibody) Key Players Head office and Area Served
3.4 Key Players CD163(Antibody) Product Solution and Service
3.5 Date of Enter into CD163(Antibody) Market
3.6 Mergers & Acquisitions, Expansion Plans

4 BREAKDOWN DATA BY TYPE (2015-2026)

4.1 Global CD163(Antibody) Historic Market Size by Type (2015-2020)
4.2 Global CD163(Antibody) Forecasted Market Size by Type (2021-2026)

5 CD163(ANTIBODY) BREAKDOWN DATA BY APPLICATION (2015-2026)

5.1 Global CD163(Antibody) Market Size by Application (2015-2020)
5.2 Global CD163(Antibody) Forecasted Market Size by Application (2021-2026)

6 NORTH AMERICA

6.1 North America CD163(Antibody) Market Size (2015-2020)
6.2 CD163(Antibody) Key Players in North America (2019-2020)
6.3 North America CD163(Antibody) Market Size by Type (2015-2020)
6.4 North America CD163(Antibody) Market Size by Application (2015-2020)

7 EUROPE

7.1 Europe CD163(Antibody) Market Size (2015-2020)
7.2 CD163(Antibody) Key Players in Europe (2019-2020)
7.3 Europe CD163(Antibody) Market Size by Type (2015-2020)
7.4 Europe CD163(Antibody) Market Size by Application (2015-2020)

8 CHINA

8.1 China CD163(Antibody) Market Size (2015-2020)
8.2 CD163(Antibody) Key Players in China (2019-2020)
8.3 China CD163(Antibody) Market Size by Type (2015-2020)
8.4 China CD163(Antibody) Market Size by Application (2015-2020)

9 JAPAN

9.1 Japan CD163(Antibody) Market Size (2015-2020)
9.2 CD163(Antibody) Key Players in Japan (2019-2020)
9.3 Japan CD163(Antibody) Market Size by Type (2015-2020)
9.4 Japan CD163(Antibody) Market Size by Application (2015-2020)

10 SOUTHEAST ASIA

10.1 Southeast Asia CD163(Antibody) Market Size (2015-2020)
10.2 CD163(Antibody) Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia CD163(Antibody) Market Size by Type (2015-2020)
10.4 Southeast Asia CD163(Antibody) Market Size by Application (2015-2020)

11 INDIA

11.1 India CD163(Antibody) Market Size (2015-2020)
11.2 CD163(Antibody) Key Players in India (2019-2020)
11.3 India CD163(Antibody) Market Size by Type (2015-2020)
11.4 India CD163(Antibody) Market Size by Application (2015-2020)

12 CENTRAL & SOUTH AMERICA

12.1 Central & South America CD163(Antibody) Market Size (2015-2020)
12.2 CD163(Antibody) Key Players in Central & South America (2019-2020)
12.3 Central & South America CD163(Antibody) Market Size by Type (2015-2020)
12.4 Central & South America CD163(Antibody) Market Size by Application (2015-2020)

13 KEY PLAYERS PROFILES

13.1 Abbexa Ltd(UK)
  13.1.1 Abbexa Ltd(UK) Company Details
  13.1.2 Abbexa Ltd(UK) Business Overview and Its Total Revenue
  13.1.3 Abbexa Ltd(UK) CD163(Antibody) Introduction
  13.1.4 Abbexa Ltd(UK) Revenue in CD163(Antibody) Business (2015-2020))
  13.1.5 Abbexa Ltd(UK) Recent Development
13.2 Atlas Antibodies(Sweden)
  13.2.1 Atlas Antibodies(Sweden) Company Details
  13.2.2 Atlas Antibodies(Sweden) Business Overview and Its Total Revenue
  13.2.3 Atlas Antibodies(Sweden) CD163(Antibody) Introduction
  13.2.4 Atlas Antibodies(Sweden) Revenue in CD163(Antibody) Business (2015-2020)
  13.2.5 Atlas Antibodies(Sweden) Recent Development
13.3 Boster Biological Technology(USA)
  13.3.1 Boster Biological Technology(USA) Company Details
  13.3.2 Boster Biological Technology(USA) Business Overview and Its Total Revenue
  13.3.3 Boster Biological Technology(USA) CD163(Antibody) Introduction
  13.3.4 Boster Biological Technology(USA) Revenue in CD163(Antibody) Business (2015-2020)
  13.3.5 Boster Biological Technology(USA) Recent Development
13.4 Biobyt(UK)
  13.4.1 Biobyt(UK) Company Details
  13.4.2 Biobyt(UK) Business Overview and Its Total Revenue
  13.4.3 Biobyt(UK) CD163(Antibody) Introduction
  13.4.4 Biobyt(UK) Revenue in CD163(Antibody) Business (2015-2020)
  13.4.5 Biobyt(UK) Recent Development
13.5 Bio-Rad(US)
  13.5.1 Bio-Rad(US) Company Details
  13.5.2 Bio-Rad(US) Business Overview and Its Total Revenue
  13.5.3 Bio-Rad(US) CD163(Antibody) Introduction
  13.5.4 Bio-Rad(US) Revenue in CD163(Antibody) Business (2015-2020)
  13.5.5 Bio-Rad(US) Recent Development
13.6 Bioss Antibodies(US)
  13.6.1 Bioss Antibodies(US) Company Details
  13.6.2 Bioss Antibodies(US) Business Overview and Its Total Revenue
  13.6.3 Bioss Antibodies(US) CD163(Antibody) Introduction
  13.6.4 Bioss Antibodies(US) Revenue in CD163(Antibody) Business (2015-2020)
  13.6.5 Bioss Antibodies(US) Recent Development
13.7 BioLegend(US)
  13.7.1 BioLegend(US) Company Details
  13.7.2 BioLegend(US) Business Overview and Its Total Revenue
  13.7.3 BioLegend(US) CD163(Antibody) Introduction
  13.7.4 BioLegend(US) Revenue in CD163(Antibody) Business (2015-2020)
  13.7.5 BioLegend(US) Recent Development
13.8 Lifespan Biosciences(US)
  13.8.1 Lifespan Biosciences(US) Company Details
  13.8.2 Lifespan Biosciences(US) Business Overview and Its Total Revenue
  13.8.3 Lifespan Biosciences(US) CD163(Antibody) Introduction
  13.8.4 Lifespan Biosciences(US) Revenue in CD163(Antibody) Business (2015-2020)
  13.8.5 Lifespan Biosciences(US) Recent Development
13.9 MBL(US)
  13.9.1 MBL(US) Company Details
  13.9.2 MBL(US) Business Overview and Its Total Revenue
  13.9.3 MBL(US) CD163(Antibody) Introduction
  13.9.4 MBL(US) Revenue in CD163(Antibody) Business (2015-2020)
  13.9.5 MBL(US) Recent Development
13.10 Novus Biologicals(US)
  13.10.1 Novus Biologicals(US) Company Details
  13.10.2 Novus Biologicals(US) Business Overview and Its Total Revenue
  13.10.3 Novus Biologicals(US) CD163(Antibody) Introduction
  13.10.4 Novus Biologicals(US) Revenue in CD163(Antibody) Business (2015-2020)
  13.10.5 Novus Biologicals(US) Recent Development
13.11 ProSci(US)
  10.11.1 ProSci(US) Company Details
  10.11.2 ProSci(US) Business Overview and Its Total Revenue
  10.11.3 ProSci(US) CD163(Antibody) Introduction
  10.11.4 ProSci(US) Revenue in CD163(Antibody) Business (2015-2020)
  10.11.5 ProSci(US) Recent Development
13.12 Proteintech(US)
  10.12.1 Proteintech(US) Company Details
  10.12.2 Proteintech(US) Business Overview and Its Total Revenue
  10.12.3 Proteintech(US) CD163(Antibody) Introduction
  10.12.4 Proteintech(US) Revenue in CD163(Antibody) Business (2015-2020)
  10.12.5 Proteintech(US) Recent Development
13.13 R&D Systems(US)
  10.13.1 R&D Systems(US) Company Details
  10.13.2 R&D Systems(US) Business Overview and Its Total Revenue
  10.13.3 R&D Systems(US) CD163(Antibody) Introduction
  10.13.4 R&D Systems(US) Revenue in CD163(Antibody) Business (2015-2020)
  10.13.5 R&D Systems(US) Recent Development
13.14 Thermo Fisher Scientific(US)
  10.14.1 Thermo Fisher Scientific(US) Company Details
  10.14.2 Thermo Fisher Scientific(US) Business Overview and Its Total Revenue
  10.14.3 Thermo Fisher Scientific(US) CD163(Antibody) Introduction
  10.14.4 Thermo Fisher Scientific(US) Revenue in CD163(Antibody) Business (2015-2020)
  10.14.5 Thermo Fisher Scientific(US) Recent Development
13.15 USBiological(US)
  10.15.1 USBiological(US) Company Details
  10.15.2 USBiological(US) Business Overview and Its Total Revenue
  10.15.3 USBiological(US) CD163(Antibody) Introduction
  10.15.4 USBiological(US) Revenue in CD163(Antibody) Business (2015-2020)
  10.15.5 USBiological(US) Recent Development
13.16 Aviva Systems Biology Corporation(USA)
  10.16.1 Aviva Systems Biology Corporation(USA) Company Details
  10.16.2 Aviva Systems Biology Corporation(USA) Business Overview and Its Total Revenue
  10.16.3 Aviva Systems Biology Corporation(USA) CD163(Antibody) Introduction
  10.16.4 Aviva Systems Biology Corporation(USA) Revenue in CD163(Antibody) Business (2015-2020)
  10.16.5 Aviva Systems Biology Corporation(USA) Recent Development
13.17 Epigentek(US)
  10.17.1 Epigentek(US) Company Details
  10.17.2 Epigentek(US) Business Overview and Its Total Revenue
  10.17.3 Epigentek(US) CD163(Antibody) Introduction
  10.17.4 Epigentek(US) Revenue in CD163(Antibody) Business (2015-2020)
  10.17.5 Epigentek(US) Recent Development

14 ANALYST'S VIEWPOINTS/CONCLUSIONS

15 APPENDIX

15.1 Research Methodology
  15.1.1 Methodology/Research Approach
  15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details

List Of Tables

LIST OF TABLES

Table 1. CD163(Antibody) Key Market Segments
Table 2. Key Players Covered: Ranking by CD163(Antibody) Revenue
Table 3. Ranking of Global Top CD163(Antibody) Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global CD163(Antibody) Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Above 90%
Table 6. Key Players of Above 95%
Table 7. Key Players of Above 99%
Table 8. Key Players of Others
Table 9. COVID-19 Impact Global Market: (Four CD163(Antibody) Market Size Forecast Scenarios)
Table 10. Opportunities and Trends for CD163(Antibody) Players in the COVID-19 Landscape
Table 11. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 12. Key Regions/Countries Measures against Covid-19 Impact
Table 13. Proposal for CD163(Antibody) Players to Combat Covid-19 Impact
Table 14. Global CD163(Antibody) Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 15. Global CD163(Antibody) Market Size by Regions (US$ Million): 2020 VS 2026
Table 16. Global CD163(Antibody) Market Size by Regions (2015-2020) (US$ Million)
Table 17. Global CD163(Antibody) Market Share by Regions (2015-2020)
Table 18. Global CD163(Antibody) Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 19. Global CD163(Antibody) Market Share by Regions (2021-2026)
Table 20. Market Top Trends
Table 21. Key Drivers: Impact Analysis
Table 22. Key Challenges
Table 23. CD163(Antibody) Market Growth Strategy
Table 24. Main Points Interviewed from Key CD163(Antibody) Players
Table 25. Global CD163(Antibody) Revenue by Players (2015-2020) (Million US$)
Table 26. Global CD163(Antibody) Market Share by Players (2015-2020)
Table 27. Global Top CD163(Antibody) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CD163(Antibody) as of 2019)
Table 28. Global CD163(Antibody) by Players Market Concentration Ratio (CR5 and HHI)
Table 29. Key Players Headquarters and Area Served
Table 30. Key Players CD163(Antibody) Product Solution and Service
Table 31. Date of Enter into CD163(Antibody) Market
Table 32. Mergers & Acquisitions, Expansion Plans
Table 33. Global CD163(Antibody) Market Size by Type (2015-2020) (Million US$)
Table 34. Global CD163(Antibody) Market Size Share by Type (2015-2020)
Table 35. Global CD163(Antibody) Revenue Market Share by Type (2021-2026)
Table 36. Global CD163(Antibody) Market Size Share by Application (2015-2020)
Table 37. Global CD163(Antibody) Market Size by Application (2015-2020) (Million US$)
Table 38. Global CD163(Antibody) Market Size Share by Application (2021-2026)
Table 39. North America Key Players CD163(Antibody) Revenue (2019-2020) (Million US$)
Table 40. North America Key Players CD163(Antibody) Market Share (2019-2020)
Table 41. North America CD163(Antibody) Market Size by Type (2015-2020) (Million US$)
Table 42. North America CD163(Antibody) Market Share by Type (2015-2020)
Table 43. North America CD163(Antibody) Market Size by Application (2015-2020) (Million US$)
Table 44. North America CD163(Antibody) Market Share by Application (2015-2020)
Table 45. Europe Key Players CD163(Antibody) Revenue (2019-2020) (Million US$)
Table 46. Europe Key Players CD163(Antibody) Market Share (2019-2020)
Table 47. Europe CD163(Antibody) Market Size by Type (2015-2020) (Million US$)
Table 48. Europe CD163(Antibody) Market Share by Type (2015-2020)
Table 49. Europe CD163(Antibody) Market Size by Application (2015-2020) (Million US$)
Table 50. Europe CD163(Antibody) Market Share by Application (2015-2020)
Table 51. China Key Players CD163(Antibody) Revenue (2019-2020) (Million US$)
Table 52. China Key Players CD163(Antibody) Market Share (2019-2020)
Table 53. China CD163(Antibody) Market Size by Type (2015-2020) (Million US$)
Table 54. China CD163(Antibody) Market Share by Type (2015-2020)
Table 55. China CD163(Antibody) Market Size by Application (2015-2020) (Million US$)
Table 56. China CD163(Antibody) Market Share by Application (2015-2020)
Table 57. Japan Key Players CD163(Antibody) Revenue (2019-2020) (Million US$)
Table 58. Japan Key Players CD163(Antibody) Market Share (2019-2020)
Table 59. Japan CD163(Antibody) Market Size by Type (2015-2020) (Million US$)
Table 60. Japan CD163(Antibody) Market Share by Type (2015-2020)
Table 61. Japan CD163(Antibody) Market Size by Application (2015-2020) (Million US$)
Table 62. Japan CD163(Antibody) Market Share by Application (2015-2020)
Table 63. Southeast Asia Key Players CD163(Antibody) Revenue (2019-2020) (Million US$)
Table 64. Southeast Asia Key Players CD163(Antibody) Market Share (2019-2020)
Table 65. Southeast Asia CD163(Antibody) Market Size by Type (2015-2020) (Million US$)
Table 66. Southeast Asia CD163(Antibody) Market Share by Type (2015-2020)
Table 67. Southeast Asia CD163(Antibody) Market Size by Application (2015-2020) (Million US$)
Table 68. Southeast Asia CD163(Antibody) Market Share by Application (2015-2020)
Table 69. India Key Players CD163(Antibody) Revenue (2019-2020) (Million US$)
Table 70. India Key Players CD163(Antibody) Market Share (2019-2020)
Table 71. India CD163(Antibody) Market Size by Type (2015-2020) (Million US$)
Table 72. India CD163(Antibody) Market Share by Type (2015-2020)
Table 73. India CD163(Antibody) Market Size by Application (2015-2020) (Million US$)
Table 74. India CD163(Antibody) Market Share by Application (2015-2020)
Table 75. Central & South America Key Players CD163(Antibody) Revenue (2019-2020) (Million US$)
Table 76. Central & South America Key Players CD163(Antibody) Market Share (2019-2020)
Table 77. Central & South America CD163(Antibody) Market Size by Type (2015-2020) (Million US$)
Table 78. Central & South America CD163(Antibody) Market Share by Type (2015-2020)
Table 79. Central & South America CD163(Antibody) Market Size by Application (2015-2020) (Million US$)
Table 80. Central & South America CD163(Antibody) Market Share by Application (2015-2020)
Table 81. Abbexa Ltd(UK) Company Details
Table 82. Abbexa Ltd(UK) Business Overview
Table 83. Abbexa Ltd(UK) Product
Table 84. Abbexa Ltd(UK) Revenue in CD163(Antibody) Business (2015-2020) (Million US$)
Table 85. Abbexa Ltd(UK) Recent Development
Table 86. Atlas Antibodies(Sweden) Company Details
Table 87. Atlas Antibodies(Sweden) Business Overview
Table 88. Atlas Antibodies(Sweden) Product
Table 89. Atlas Antibodies(Sweden) Revenue in CD163(Antibody) Business (2015-2020) (Million US$)
Table 90. Atlas Antibodies(Sweden) Recent Development
Table 91. Boster Biological Technology(USA) Company Details
Table 92. Boster Biological Technology(USA) Business Overview
Table 93. Boster Biological Technology(USA) Product
Table 94. Boster Biological Technology(USA) Revenue in CD163(Antibody) Business (2015-2020) (Million US$)
Table 95. Boster Biological Technology(USA) Recent Development
Table 96. Biobyt(UK) Company Details
Table 97. Biobyt(UK) Business Overview
Table 98. Biobyt(UK) Product
Table 99. Biobyt(UK) Revenue in CD163(Antibody) Business (2015-2020) (Million US$)
Table 100. Biobyt(UK) Recent Development
Table 101. Bio-Rad(US) Company Details
Table 102. Bio-Rad(US) Business Overview
Table 103. Bio-Rad(US) Product
Table 104. Bio-Rad(US) Revenue in CD163(Antibody) Business (2015-2020) (Million US$)
Table 105. Bio-Rad(US) Recent Development
Table 106. Bioss Antibodies(US) Company Details
Table 107. Bioss Antibodies(US) Business Overview
Table 108. Bioss Antibodies(US) Product
Table 109. Bioss Antibodies(US) Revenue in CD163(Antibody) Business (2015-2020) (Million US$)
Table 110. Bioss Antibodies(US) Recent Development
Table 111. BioLegend(US) Company Details
Table 112. BioLegend(US) Business Overview
Table 113. BioLegend(US) Product
Table 114. BioLegend(US) Revenue in CD163(Antibody) Business (2015-2020) (Million US$)
Table 115. BioLegend(US) Recent Development
Table 116. Lifespan Biosciences(US) Business Overview
Table 117. Lifespan Biosciences(US) Product
Table 118. Lifespan Biosciences(US) Company Details
Table 119. Lifespan Biosciences(US) Revenue in CD163(Antibody) Business (2015-2020) (Million US$)
Table 120. Lifespan Biosciences(US) Recent Development
Table 121. MBL(US) Company Details
Table 122. MBL(US) Business Overview
Table 123. MBL(US) Product
Table 124. MBL(US) Revenue in CD163(Antibody) Business (2015-2020) (Million US$)
Table 125. MBL(US) Recent Development
Table 126. Novus Biologicals(US) Company Details
Table 127. Novus Biologicals(US) Business Overview
Table 128. Novus Biologicals(US) Product
Table 129. Novus Biologicals(US) Revenue in CD163(Antibody) Business (2015-2020) (Million US$)
Table 130. Novus Biologicals(US) Recent Development
Table 131. ProSci(US) Company Details
Table 132. ProSci(US) Business Overview
Table 133. ProSci(US) Product
Table 134. ProSci(US) Revenue in CD163(Antibody) Business (2015-2020) (Million US$)
Table 135. ProSci(US) Recent Development
Table 136. Proteintech(US) Company Details
Table 137. Proteintech(US) Business Overview
Table 138. Proteintech(US) Product
Table 139. Proteintech(US) Revenue in CD163(Antibody) Business (2015-2020) (Million US$)
Table 140. Proteintech(US) Recent Development
Table 141. R&D Systems(US) Company Details
Table 142. R&D Systems(US) Business Overview
Table 143. R&D Systems(US) Product
Table 144. R&D Systems(US) Revenue in CD163(Antibody) Business (2015-2020) (Million US$)
Table 145. R&D Systems(US) Recent Development
Table 146. Thermo Fisher Scientific(US) Company Details
Table 147. Thermo Fisher Scientific(US) Business Overview
Table 148. Thermo Fisher Scientific(US) Product
Table 149. Thermo Fisher Scientific(US) Revenue in CD163(Antibody) Business (2015-2020) (Million US$)
Table 150. Thermo Fisher Scientific(US) Recent Development
Table 151. USBiological(US) Company Details
Table 152. USBiological(US) Business Overview
Table 153. USBiological(US) Product
Table 154. USBiological(US) Revenue in CD163(Antibody) Business (2015-2020) (Million US$)
Table 155. USBiological(US) Recent Development
Table 156. Aviva Systems Biology Corporation(USA) Company Details
Table 157. Aviva Systems Biology Corporation(USA) Business Overview
Table 158. Aviva Systems Biology Corporation(USA) Product
Table 159. Aviva Systems Biology Corporation(USA) Revenue in CD163(Antibody) Business (2015-2020) (Million US$)
Table 160. Aviva Systems Biology Corporation(USA) Recent Development
Table 161. Epigentek(US) Company Details
Table 162. Epigentek(US) Business Overview
Table 163. Epigentek(US) Product
Table 164. Epigentek(US) Revenue in CD163(Antibody) Business (2015-2020) (Million US$)
Table 165. Epigentek(US) Recent Development
Table 166. Research Programs/Design for This Report
Table 167. Key Data Information from Secondary Sources
Table 168. Key Data Information from Primary Sources

List Of Figures

LIST OF FIGURES

Figure 1. Global CD163(Antibody) Market Share by Type: 2020 VS 2026
Figure 2. Above 90% Features
Figure 3. Above 95% Features
Figure 4. Above 99% Features
Figure 5. Others Features
Figure 6. Global CD163(Antibody) Market Share by Application: 2020 VS 2026
Figure 7. Biopharmaceutical Companies Case Studies
Figure 8. Hospitals Case Studies
Figure 9. Bioscience Research Institutions Case Studies
Figure 10. Others Case Studies
Figure 11. CD163(Antibody) Report Years Considered
Figure 12. Global CD163(Antibody) Market Size YoY Growth 2015-2026 (US$ Million)
Figure 13. Global CD163(Antibody) Market Share by Regions: 2020 VS 2026
Figure 14. Global CD163(Antibody) Market Share by Regions (2021-2026)
Figure 15. Porter's Five Forces Analysis
Figure 16. Global CD163(Antibody) Market Share by Players in 2019
Figure 17. Global Top CD163(Antibody) Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in CD163(Antibody) as of 2019
Figure 18. The Top 10 and 5 Players Market Share by CD163(Antibody) Revenue in 2019
Figure 19. North America CD163(Antibody) Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. Europe CD163(Antibody) Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. China CD163(Antibody) Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Japan CD163(Antibody) Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Southeast Asia CD163(Antibody) Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. India CD163(Antibody) Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Central & South America CD163(Antibody) Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Abbexa Ltd(UK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Abbexa Ltd(UK) Revenue Growth Rate in CD163(Antibody) Business (2015-2020)
Figure 28. Atlas Antibodies(Sweden) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Atlas Antibodies(Sweden) Revenue Growth Rate in CD163(Antibody) Business (2015-2020)
Figure 30. Boster Biological Technology(USA) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Boster Biological Technology(USA) Revenue Growth Rate in CD163(Antibody) Business (2015-2020)
Figure 32. Biobyt(UK) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Biobyt(UK) Revenue Growth Rate in CD163(Antibody) Business (2015-2020)
Figure 34. Bio-Rad(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 35. Bio-Rad(US) Revenue Growth Rate in CD163(Antibody) Business (2015-2020)
Figure 36. Bioss Antibodies(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 37. Bioss Antibodies(US) Revenue Growth Rate in CD163(Antibody) Business (2015-2020)
Figure 38. BioLegend(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 39. BioLegend(US) Revenue Growth Rate in CD163(Antibody) Business (2015-2020)
Figure 40. Lifespan Biosciences(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 41. Lifespan Biosciences(US) Revenue Growth Rate in CD163(Antibody) Business (2015-2020)
Figure 42. MBL(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 43. MBL(US) Revenue Growth Rate in CD163(Antibody) Business (2015-2020)
Figure 44. Novus Biologicals(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 45. Novus Biologicals(US) Revenue Growth Rate in CD163(Antibody) Business (2015-2020)
Figure 46. ProSci(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 47. ProSci(US) Revenue Growth Rate in CD163(Antibody) Business (2015-2020)
Figure 48. Proteintech(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 49. Proteintech(US) Revenue Growth Rate in CD163(Antibody) Business (2015-2020)
Figure 50. R&D Systems(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. R&D Systems(US) Revenue Growth Rate in CD163(Antibody) Business (2015-2020)
Figure 52. Thermo Fisher Scientific(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. Thermo Fisher Scientific(US) Revenue Growth Rate in CD163(Antibody) Business (2015-2020)
Figure 54. USBiological(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. USBiological(US) Revenue Growth Rate in CD163(Antibody) Business (2015-2020)
Figure 56. Aviva Systems Biology Corporation(USA) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Aviva Systems Biology Corporation(USA) Revenue Growth Rate in CD163(Antibody) Business (2015-2020)
Figure 58. Epigentek(US) Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Epigentek(US) Revenue Growth Rate in CD163(Antibody) Business (2015-2020)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed